MGTX
MeiraGTx Holdings PLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$855.71M
P/E Ratio
—
EPS
$-1.48
Beta
1.24
52W High
$11.85
52W Low
$5.02
50-Day MA
$9.12
200-Day MA
$8.24
Dividend Yield
—
Profit Margin
-151.10%
Forward P/E
1.61
PEG Ratio
—
About MeiraGTx Holdings PLC
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focused on developing treatments for patients living with serious illnesses. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $79.76M |
| Gross Profit (TTM) | $76.09M |
| EBITDA | $-92.72M |
| Operating Margin | -13931.00% |
| Return on Equity | -368.20% |
| Return on Assets | -28.10% |
| Revenue/Share (TTM) | $0.98 |
| Book Value | $-0.71 |
| Price-to-Book | 228.30 |
| Price-to-Sales (TTM) | 10.73 |
| EV/Revenue | 10.92 |
| EV/EBITDA | -3.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -84.80% |
| Shares Outstanding | $92.61M |
| Float | $52.34M |
| % Insiders | 17.80% |
| % Institutions | 60.51% |
Historical Volatility
HV 10-Day
45.38%
HV 20-Day
38.67%
HV 30-Day
85.25%
HV 60-Day
70.56%
HV Rank
85.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($28.25 target)
2
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026